| Structure | Chemical Name | CAS | MF |
|
Benzyloxy carbonyl-PEG3-acid
|
2100306-73-6
|
C17H24O7
|
|
Methoxycarbonyl-peg4-t-butyl ester
|
2100306-74-7
|
C17H32O8
|
|
N-(Biotin)-N-bis(PEG1-alcohol)
|
2100306-75-8
|
C18H33N3O6S
|
|
N-(Azido-PEG3)-N-Biotin-PEG4-methyl ester
|
2100306-76-9
|
C30H54N6O11S
|
|
Hydroxy-Amino-bis(PEG2-propargyl)
|
2100306-77-0
|
C16H27NO5
|
|
t-Butyl 3-(hydroxypropoxyl)-propanoate
|
2100306-78-1
|
C10H20O4
|
|
N-Boc-N-bis(PEG1-azide)
|
2100306-79-2
|
C13H25N7O4
|
|
Hydroxy-PEG5-methyl ester
|
2100306-80-5
|
C14H28O8
|
|
NH-bis(PEG1-azide)
|
2100306-81-6
|
C8H17N7O2
|
|
Aminooxy-PEG4-t-butyl ester
|
2100306-82-7
|
C15H31NO7
|
|
NH-bis(PEG2-propargyl)
|
2100306-83-8
|
C14H23NO4
|
|
N-(Amino-PEG4)-N-Biotin-PEG4-acid
|
2100306-84-9
|
C31H58N4O12S
|
|
N-(PEG1-OH)-N-Boc-PEG2-propargyl
|
2100306-85-0
|
C16H29NO6
|
|
N-Boc-N-bis(PEG2-propargyl)
|
2100306-86-1
|
C19H31NO6
|
|
3-Bromo-6-fluoro-5-methoxy-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide
|
2100839-49-2
|
C8H6BrFN2O3S
|
|
CCB02
|
2100864-57-9
|
C14H9N3O
|
|
Dapagliflozin Open Ring
|
2100872-88-4
|
C21H27ClO7
|
|
E3 ligase Ligand-Linker Conjugates 3
|
2101200-09-1
|
C26H35N7O5S
|
|
PROTAC BRD4-binding moiety 1
|
2101200-10-4
|
C23H21N3O2
|
|
NHPI-PEG3-C2-NHS ester
|
2101206-14-6
|
C21H24N2O10
|
|
tert-butyl 3-fluoro-4-hydroxy-4-(trifluoromethyl)piperidine-1-carboxylate
|
2101206-18-0
|
C11H17F4NO3
|
|
2,3,4,5,6-Pentafluorophenyl 3-[2-(2-{2-[(4-formylphenyl)formamido]ethoxy}ethoxy)ethoxy]propanoate
|
2101206-21-5
|
C23H22F5NO7
|
|
2,5-Dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate
|
2101206-29-3
|
C14H16N2O4S2
|
|
2,5-Dioxopyrrolidin-1-yl 11-oxo-4,7,13-trioxa-10-azahexadec-15-yn-1-oate
|
2101206-30-6
|
C16H22N2O8
|
|
2,5-Dioxopyrrolidin-1-yl 3-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)propanoate
|
2101206-31-7
|
C19H20N2O9
|
|
Propanoic acid, 3-[2-[2-[2-[(4-formylbenzoyl)amino]ethoxy]ethoxy]ethoxy]-, 2,5-dioxo-1-pyrrolidinyl ester
|
2101206-32-8
|
C21H26N2O9
|
|
2-Ethyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hydrochloride
|
2101206-35-1
|
C8H14ClN3
|
|
Esomeprazole Impurity 17
|
2101206-41-9
|
C26H30N4O5S
|
|
4-Ethyl-3-ethynylbenzoic acid
|
2101206-43-1
|
C11H10O2
|
|
Py-ds-dMBut-OPFP
|
2101206-44-2
|
C17H14F5NO2S2
|
|
3,6,9-Trioxa-12-azapentadecanoic acid, 15-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-13-oxo-, 2,5-dioxo-1-pyrrolidinyl ester
|
2101206-45-3
|
C19H25N3O10
|
|
Perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate
|
2101206-46-4
|
C25H24F5NO9
|
|
Perfluorophenyl 3-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)propanoate
|
2101206-47-5
|
C21H16F5NO7
|
|
5,8,11-Trioxa-2-azatetradecanedioic acid, 1-(bicyclo[6.1.0]non-4-yn-9-ylmethyl) 14-(2,3,4,5,6-pentafluorophenyl) ester
|
2101206-48-6
|
C26H30F5NO7
|
|
tert-butyl 3-bromo-4-hydroxy-4-(trifluoromethyl)piperidine-1-carboxylate
|
2101206-52-2
|
C11H17BrF3NO3
|
|
2101206-56-6
|
2101206-56-6
|
C7H15BrN2O
|
|
2-Amino-N-(5-bromopentyl)acetamide hydrochloride
|
2101206-57-7
|
C7H16BrClN2O
|
|
Perfluorophenyl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate
|
2101206-60-2
|
C21H18F5NO6
|
|
Propanoic acid, 3-[2-[2-[[2-(2-cyclooctyn-1-yloxy)acetyl]amino]ethoxy]ethoxy]-, 2,3,4,5,6-pentafluorophenyl ester
|
2101206-61-3
|
C23H26F5NO6
|
|
tert-butyl Trans-3-((tert-butoxycarbonyl)oxy)-4-fluoropiperidine-1-carboxylate racemate
|
2101206-65-7
|
C15H26FNO5
|
|
Omeprazole Impurity 25
|
2101206-66-8
|
C26H30N4O4S
|
|
Perfluorophenyl 3-(2-(4-formylbenzamido)ethoxy)propanoate
|
2101206-67-9
|
C19H14F5NO5
|
|
4,7,10,16-Tetraoxa-13-azanonadec-18-ynoic acid, 14-oxo-, 2,5-dioxo-1-pyrrolidinyl ester
|
2101206-78-2
|
C18H26N2O9
|
|
2,5-Dioxopyrrolidin-1-yl 3-(2-(4-formylbenzamido)ethoxy)propanoate
|
2101206-80-6
|
C17H18N2O7
|
|
1-(4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid
|
2101206-86-2
|
C15H18N2O7S3
|
|
Perfluorophenyl 3-(2-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)ethoxy)propanoate
|
2101206-87-3
|
C23H20F5NO8
|
|
3',3'-Difluoro-1,4'-bipiperidine dihydrochloride
|
2101206-90-8
|
C10H20Cl2F2N2
|
|
2,5-Dioxopyrrolidin-1-yl 17-oxo-4,7,10,13,19-pentaoxa-16-azadocos-21-yn-1-oate
|
2101206-92-0
|
C20H30N2O10
|
|
endo-BCN-PEG3-NHS ester
|
2101206-94-2
|
C24H34N2O9
|
|
tert-butyl 3',3'-difluoro-1,4'-bipiperidine-1'-carboxylate
|
2101206-97-5
|
C15H26F2N2O2
|
|
7-tert-Butyl 2-methyl 5,6-dihydroimidazo[1,2-a]pyrazine-2,7(8H)-dicarboxylate
|
2101207-00-3
|
C13H19N3O4
|
|
1-benzyl-4-benzylidene-3,3-difluoropiperidine
|
2101208-37-9
|
C19H19F2N
|
|
1-benzyl-3,3-difluoro-4-(4-fluorobenzylidene)piperidine
|
2101208-40-4
|
C19H18F3N
|
|
tert-butyl trans-3-amino-5-methoxypiperidine-1-carboxylate
|
2101218-49-7
|
C11H22N2O3
|
|
benzyl 5-((tert-butoxycarbonyl)amino)-2-methylpiperidine-1-carboxylate
|
2101218-65-7
|
C19H28N2O4
|
|
tert-butyl cis-3-amino-5-methoxypiperidine-1-carboxylate
|
2101218-75-9
|
C11H22N2O3
|
|
(3R,5S)-rel-5-([1,1''-biphenyl]-4-ylmethyl)-3-methyl-2-Pyrrolidinone
|
2101222-51-7
|
C18H19NO
|
|
(R)-2-(TERT-BUTOXYCARBONYL)-5-(METHYLSULFONYL)ISOINDOLINE-1-CARBOXYLIC ACID
|
2101238-70-2
|
C15H19NO6S
|
|
Tipiracil Impurity 2
|
2101241-71-6
|
C9H10ClN3O3
|
|
Lead(Ii) Iodide/Methylammonium Iodide(1:1)-Dmf Complex
|
2101242-86-6
|
C4H16I3N2OPb
|
|
AZD-0284
|
2101291-07-8
|
C21H18F6N2O5S
|
|
4(3H)-Quinazolinone, 7-bromo-5-fluoro-
|
2101294-63-5
|
C8H4BrFN2O
|
|
GSK690
|
2101305-84-2
|
C24H23N3O
|
|
Olmesartan Medoxomil Impurity 10
|
2101308-73-8
|
C44H40N6O3
|
|
Olmesartan Medoxomil Impurity 7
|
2101308-74-9
|
C44H40N6O3
|
|
(R)-DMT-glycidol-C(Bz)
|
2101315-01-7
|
C35H33N3O6
|
|
Gboxin
|
2101315-36-8
|
C22H33ClN2O2
|
|
S-GBOXIN
|
2101317-21-7
|
C27H32F3IN2O2
|
|
1-Piperidinecarboxylic acid, 3-amino-5-hydroxy-, 1,1-dimethylethyl ester, (3R,5R)-rel-
|
2101332-43-6
|
C10H20N2O3
|
|
tert-Butyl (1R,4R,7R)-2-azabicyclo[2.2.1]heptan-7-ylcarbamate
|
2101335-28-6
|
C11H20N2O2
|
|
(3AR,3a'R,8aS,8a'S)-2,2'-(1-phenylpropane-2,2-diyl)bis(8,8a-dihydro-3aH-indeno[1,2-d]oxazole)
|
2101474-75-1
|
C29H26N2O2
|
|
1-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridin-1-yl]ethanone
|
2101498-92-2
|
C13H22BNO3
|
|
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine hydrochloride
|
2101498-93-3
|
C11H21BClNO2
|
|
Cefazolin-13C2-15N
|
2101505-58-0
|
C14H14N8O4S3
|
|
(2R)-2-({[3,5-bis(trifluoromethyl)phenyl]carbamothioyl}amino)-N-(2,4-difluorophenyl)-2-phenylacetamide
|
2101517-69-3
|
C23H15F8N3OS
|
|
N-(4-(4-fluorophenyl)-5-formyl-6-isopropylpyrimidin-2-yl)-2-
hydroxy-N,2-dimethylpropane-1-sulfonamide
|
2101546-09-0
|
C19H24FN3O4S
|
|
3,3'-Bi-9H-carbazole, 9-[1,1'-biphenyl]-3-yl-9'-[1,1':4',1''-terphenyl]-4-yl-
|
2101561-65-1
|
C54H36N2
|
|
3-Thia-8-azabicyclo[3.2.1]octane 3,3-dioxide hydrochloride (1:1)
|
2101562-66-5
|
C6H12ClNO2S
|
|
Fmoc-n-amido-peg10-acid
|
2101563-45-3
|
C38H57NO14
|
|
5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80,83,86-Octacosaoxa-2-azanonaoctacontanedioic acid, 1-(9H-fluoren-9-ylmethyl) ester
|
2101605-02-9
|
C74H129NO32
|
|
Tetraxetan Related Compound A (25 mg) (2,2',2"-[10-(2-Ethoxy-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetic acid)
|
2101625-18-5
|
C18H32N4O8
|
|
GSK2894631A
|
2101626-26-8
|
C20H24F2N2O3
|
|
1H-Pyrrolizine-7a(5H)-carboxylic acid, 2-fluorotetrahydro-5-oxo-, ethyl ester, (2R,7aS)-
|
2101633-12-7
|
C10H14FNO3
|
|
3,3''-diamino-[1,1':4',1''-terphenyl]-4,4''-dicarboxylic acid
|
2101636-51-3
|
C20H16N2O4
|
|
Benzoic acid, 4,4'-(9,10-anthracenediyl)bis[2-amino-
|
2101636-53-5
|
C28H20N2O4
|
|
Hexanoic acid, 3-(chloromethyl)-, (3R)-
|
2101641-90-9
|
C7H13ClO2
|
|
(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanoic acid
|
2101641-92-1
|
C11H17NO4
|
|
1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide
|
2101651-50-5
|
C14H12FN5
|
|
6-bromo-8-iodoquinolin-2(1H)-one
|
2101658-56-2
|
C9H5BrINO
|
|
2-{2-[2,6-bis({bis[(tert-butoxy)carbonyl]amino})-9H-purin-9-yl]-N-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)ethyl]acetamido}acetic acid
|
2101661-88-3
|
C46H58N8O13
|
|
1H-Pyrazole-4-carboxamide, 5-amino-3-[4-[[(5-fluoro-2-methoxybenzoyl)amino]methyl]phenyl]-1-[(1R)-2,2,2-trifluoro-1-methylethyl]-
|
2101700-14-3
|
C22H21F4N5O3
|
|
Pirtobrutinib
|
2101700-15-4
|
C22H21F4N5O3
|
|
2-(4-((8-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)amino)-1H-pyrazol-1-yl)acetic acid(WXC06418)
|
2101710-31-8
|
C11H9BrN6O2
|
|
Mal-amido-PEG12-NHS ester
|
2101722-60-3
|
C38H63N3O19
|
|
RAD51-IN-17
|
2101739-18-6
|
C22H16ClN3O
|
|
DRI-C21045
(DRI C21045)
|
2101765-81-3
|
C32H24N2O7S
|
|
(7R,8aS)-octahydropyrrolo[1,2-a]piperazin-7-o oxalic acid
|
2101775-04-4
|
C9H16N2O5
|
|
Methyl (3R,4R)-4-methylpyrrolidine-3-carboxylate hydrochloride
|
2101775-05-5
|
C7H14ClNO2
|
|
methyl exo-9-azabicyclo[3.3.1]nonane-3-carboxylate hydrochloride
|
2101775-07-7
|
C10H18ClNO2
|
|
tert-butyl N-{[(2S,4S)-4-fluoropyrrolidin-2-yl]methyl}carbamate hydrochloride
|
2101775-09-9
|
C10H20ClFN2O2
|